用个性化深度学习提升1型糖尿病低血糖预测精度。
Tailoring Adverse Event Prediction in Type 1 Diabetes with Patient-Specific Deep Learning Models
- 基于患者特有数据构建深度学习模型,捕捉个体差异。
- 相比传统方法,显著提高不良事件预测准确率。
- 适合可穿戴设备与移动健康平台的精准糖尿病管理。
1型糖尿病的有效管理依赖于持续血糖监测和精准胰岛素调整,以预防高/低血糖。随着可穿戴血糖监测设备和移动健康应用的普及,精确的血糖预测对提升自动胰岛素输注和决策支持系统至关重要。本文提出一种基于深度学习的个性化血糖预测方法,利用患者特有数据提升真实场景下的预测精度与响应速度。不同于传统通用模型,该方法考虑个体差异,实现更有效的个体化预测。通过留一患者交叉验证与微调策略对比,验证了个性化模型在建模患者特异性动态方面的优势。实验表明,个性化模型显著提升了不良事件的预测能力,支持更精准及时的干预。我们还比较了多模态患者特有方法与仅使用CGM的传统方法,并通过消融实验确定了有效个性化所需的最小数据量——这对实际应用中数据收集困难的情况尤为重要。研究结果凸显了自适应个性化血糖预测模型在下一代糖尿病管理中的潜力,尤其适用于可穿戴与移动健康平台,推动面向消费者端的糖尿病护理解决方案发展。
原文摘要 · Abstract (English)
Effective management of Type 1 Diabetes requires continuous glucose monitoring and precise insulin adjustments to prevent hyperglycemia and hypoglycemia. With the growing adoption of wearable glucose monitors and mobile health applications, accurate blood glucose prediction is essential for enhancing automated insulin delivery and decision-support systems. This paper presents a deep learning-based approach for personalized blood glucose prediction, leveraging patient-specific data to improve prediction accuracy and responsiveness in real-world scenarios. Unlike traditional generalized models, our method accounts for individual variability, enabling more effective subject-specific predictions. We compare Leave-One-Subject-Out Cross-Validation with a fine-tuning strategy to evaluate their ability to model patient-specific dynamics. Results show that personalized models significantly improve the prediction of adverse events, enabling more precise and timely interventions in real-world scenarios. To assess the impact of patient-specific data, we conduct experiments comparing a multimodal, patient-specific approach against traditional CGM-only methods. Additionally, we perform an ablation study to investigate model performance with progressively smaller training sets, identifying the minimum data required for effective personalization-an essential consideration for real-world applications where extensive data collection is often challenging. Our findings underscore the potential of adaptive, personalized glucose prediction models for advancing next-generation diabetes management, particularly in wearable and mobile health platforms, enhancing consumer-oriented diabetes care solutions.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。